Join us in urging the World Health Organization to consolidate its guidance regarding the treatment for multidrug-resistant tuberculosis (MDR-TB), and in the interim, as a matter of urgency, to recommend bedaquiline as part of the preferred regimen for patients with MDR-TB in place of the injectable agent.
How would you like to sign on?
As an individual
As an organization
Never submit passwords through Google Forms.
This form was created inside of Treatment Action Group.
Terms of Service